Cargando…
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells
In several carcinomas, the SET Domain Containing 3, Actin Histidine Methyltransferase (SETD3) is associated with oncogenesis. However, there is little knowledge about the role of SETD3 in the progression and prognosis of breast cancer. In this study, we first analyzed the prognostic value of SETD3 i...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010743/ https://www.ncbi.nlm.nih.gov/pubmed/32042016 http://dx.doi.org/10.1038/s41598-020-59057-5 |